The majority of orphan drugs are subject to utilization controls in Medicare Part D plans. The use of utilization controls varies by certain drug characteristics.
Farah Yehia, PhD
Advertisement
Articles by Farah Yehia, PhD
Advertisement
Latest Updated Articles
- Predictors of Orphan Drug Coverage Restrictions in Medicare Part D
Published: September 8th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
3
Team-Based Precision Oncology: Advancing Value and Access in Cancer Care
4
From HIV Treatment Switching to Disease Prevention
5
